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Introduction
Hepatitis C infection (HCV) is the major cause of non-A, non-
B hepatitis, described as the “hidden epidemic” with an esti-
mated 170 million individuals infected world-wide. Although
HCV was first described in blood transfusion recipients, other
routes of transmission are now recognised. The importance of
sexual or household contact as modes of transmission is con-
troversial1-4 and remains to be defined. Vertical transmission
from mother to infant, originally thought to be extremely rare,
occurs in five to fifteen per cent of deliveries to HCV infected
women and will potentially impact significantly on paediatric
service requirements. To better anticipate paediatric needs, we
sought to characterise the current trends in HCV infection in
an Irish antenatal population.
Methods
Since 1994, a prospective observational study of infants born
to HCV infected mothers and referred to the Paediatric
Infectious Diseases service at The Children’s Hospital, Temple
St. and Our Lady’s Hospital for Sick Children, Crumlin is
being carried out5,6 and will be reported shortly. Infant refer-
rals are predominantly from three Dublin maternity hospitals.
Women attending antenatal clinics are offered testing for HCV
if they report risk factors for HCV acquisition (illicit drug use,
transfusion of blood/blood products, sexual contact with a
HCV infected partner, tattoos/body piercing, history of jaun-
dice), develop jaundice or abnormal liver function tests in
pregnancy, or if they request screening. In the course of the
infant study, retrospective data on maternal demographics, risk
factors for infection and laboratory results (where available)
were gathered and are presented here.
All serological and molecular testing for HCV is performed at
the Virus Reference Laboratory, University College, Dublin.
Hepatitis C antibody is detected using one or more commercial
third generation enzyme immunoassays (Ortho, Abbott
Axysm). Confirmation of antibody status is determined using
the RIBA-3 assay. Hepatitis C RNA is detected using the
Amplicor HCV assay (Roche) and an in-house RT-PCR assay
(detects >100 copies /ml). Viral load is measured by branched
DNA signal amplification (Chiron) and HCV genotype is iden-
tified by restriction fragment length polymorphism (RFLP).7
Results
Two hundred and ninety six women, 18 of whom had more
than one pregnancy, attending for antenatal care tested posi-
tive for HCV during the years 1994-1999 and presented with
their infants to the Paediatric Infectious Diseases service.
These mother-infant pairs accounted for approximately 65%
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(628 of 966) of all positive tests for hepatitis C originating
from the maternity hospitals during this period. However, as
individuals were selected for testing, and as the total number
of tests received (even if each test represented a unique
obstetric patient) represented less than 5% of the obstetric
population, no estimate of seroprevalence can be made. There
was a marked escalation in the numbers attending the service
over the years; an eight fold increase from 14 in 1994 to 111
in 1999 (Figure 1). Fifty eight per cent (184) of women
attended the Rotunda, 33% (104) the Coombe Women’s
Hospital and 8% (25) the National Maternity Hospital,
Holles Street. Maternal demographics and risk factors for
infection are shown in Table 1.
Prior to 1998 the decision to test women for HIV or hepati-
tis B surface antigen was dependent on the treating clinician.
Universal screening for HIV and hepatitis B surface antigen has
been offered in the Rotunda since January 1998. Universal
HIV screening is performed in the other hospitals since 1999.
Of 277 HCV seropositive mothers who agreed to HIV testing
in pregnancy or at delivery, 13 (4.7%) were positive. Two addi-
tional women tested HIV positive within one year after infant
delivery. Nine of 262 (3.4%) tested for hepatitis B had
detectable surface antigen.
The degree of evaluation of maternal hepatitis C infection in
pregnancy was variable. Hepatitis C genotype was defined in 51
women during the antenatal period (33 type 1, 15 type 3, 1 type
4). Assessment of maternal viraemia by polymerase chain reaction
(PCR), antenatally or peri-partum, was performed in 84 women.
HCV-RNA was detected in 46 (55%). Detection of HCV-RNA
could be intermittent in pregnancy as noted in two of four
women who were tested on more than one occasion. 
Eighty three women (26%) delivered at less than 38 weeks
gestation (range 27-37); thirty four had caesarean sections (28
elective, 6 elective) giving a caesarean section rate of 11% in this
cohort. This compared with hospital caesarean section rates of
9-19% over the same time period.
Discussion
The true seroprevalence of hepatitis C in women of child-
bearing age is not known.  Large-scale seroprevalence stud-
ies have not been done, however, the Centre for Disease
Control in Atlanta estimate that approximately 1-2% of
women of child-bearing age in the US are HCV infect-
ed.1Selective screening of high risk populations or where
clinically indicated has been the policy in Irish antenatal
clinics. This does not permit accurate determination of
seroprevalence; nevertheless the increase in the numbers of
HCV antibody positive women detected over this study
period is striking. Some of this represents improved aware-
ness and case ascertainment as the numbers of samples
received for testing in the Virus Reference Laboratory have
also increased. Most HCV infected women are Irish, with
few cases as yet identified in women from endemic areas.
IVDU is currently the primary risk factor for HCV acqui-
sition in an antenatal population. However, the number of
mothers who consistently denied IVDU, and whose only
identified risk factor is sexual contact with a known HCV
infected partner, is high (9%). While some of this may
reflect undisclosed IVDU, we believe that the risk cate-
gories as given are reliable. The role of sexual transmission
in the spread of HCV is often discounted.1-4 This study sup-
ports the view that the importance of sexual spread should
no longer be overlooked, highlighting the need for educa-
tion of the general population and the incorporation of
such information into HCV prevention strategies. Similarly,
the detection of HCV in women who do not belong to any
of the recognised “high risk” groups is worrying, suggest-
ing either greater transmissibility through sexual contact or
of the existence of other unrecognised modes of transmis-
sion. This may herald even more widespread prevalence
than previously thought.
Twenty six percent of women delivered at less than 38 weeks
gestation. However, the caesarean section rate is surprisingly
low at 11 per cent perhaps reflecting the young age of the
cohort. 
The numbers of women infected with other blood borne
viruses is low given the predominance of IVDU in this cohort
but consistent with previous reports of the prevalence of these
pathogens amongst IVDU attending Dublin treatment cen-
tres.13,14 It is not possible in this study to reliably assess the
effects of pregnancy on HCV disease activity. Few women had
evaluations of liver function or repeated measures of viral
activity during pregnancy. More than 50% of those in whom
HCV PCR testing was carried out had HCV-RNA detected.
As noted, this can be intermittent and a single negative PCR
test in pregnancy does not accurately reflect viral activity
throughout gestation. Further studies are needed to address
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Figure 1: Numbers of HCV infected women detected 1994-
1999
Table 1: Maternal demographics and risk factors for 
infection
Age at delivery (years)
Median (range) 24 (16-41) 
Nationality No (%)
Ireland 289 (97)
Africa 6 (2)
Eastern Europe 1 (<1)
Risk factors for infection No (%)
IVDU 244 (83)      
Heterosexual exposure 25 (8)     
Infected blood products 13 (7)   
Tattoos 2 (<1)      
No risk identified 9 (3)
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this question. 
HCV is transmitted vertically in 5-15% of all pregnancies in
HCV positive women.5,6,8-11 More frequent determinations of
HCV viraemia in pregnancy might permit more accurate pre-
diction of infant outcome. It is likely that for women who
remain consistently PCR negative during pregnancy the risk of
vertical transmission might approach zero.12 Knowledge of
maternal viraemia would also permit more selective targeting
of interventions to reduce transmission at women at greatest
risk, as these become available. This may become critical if
early indicators that caesarean section can significantly reduce
the risk of vertical transmission of HCV are confirmed.6
Many women in this cohort — while accessing care for their
infants — did not attend adult hepatology services and were
often poorly informed regarding their own health status. They
were often unaware of recommendations such as vaccination
against hepatotropic viruses (A and B), or restriction of alco-
hol intake in this condition. Attendance for antenatal and pae-
diatric care offers an opportunity to educate women and link
them in with appropriate services. Regular assessment of liver
function is advisable in HCV infection and this assumes even
greater importance as new and effective therapies become
available.
Conclusion
Hepatitis C is an increasingly detected problem in women
attending antenatal clinics, in part reflecting improved ascer-
tainment and perhaps reflecting increasing seroprevalence in
the community. This has implications for future resource
requirements of both adult and paediatric services. While
IVDU remains the most significant risk factor for maternal
infection, heterosexual contact with an infected partner must
not be discounted as a potential mode of spread. The detection
of HCV in women who do not belong to traditional high risk
categories may point to the need for wider screening, particu-
larly if obstetric interventions such as caesarean section are
proved to interrupt vertical transmission.6 Maternal HCV
viraemia can be variable in pregnancy. More systematic study
of HCV infection in pregnancy is needed to accurately deter-
mine seroprevalence, to define the impact of pregnancy on
HCV, and to permit more accurate prediction of infant out-
come thus facilitating selective targeting of interventions to
women at greatest risk of transmission.
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